PML and infection: ICP0 is known to localize to PML-NBs from the outset of infection in a PML isoform and SUMO-dependent manner [17, 22, 74, 75], where it targets PML and other SUMO-modified component proteins for ubiquitination and proteasome-dependent degradation [17, 25–27, 74, 75].